Complications of Anti-Vascular Endothelial Growth Factor Drugs

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|7|2|131-137

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.7, Iss.2, 2012-06, pp. : 131-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 101-116

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age- Related Macular Degeneration

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 90-95

Bentham Science Publishers

Access to resources Recommend Favorite

EDITORIAL [Hot Topic: Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Ophthalmic Conditions (Guest Editor: Michael W. Stewart)]

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 77-79

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration

By Mousa Shaker A.  

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 183-194

Adis International

Access to resources Recommend Favorite